ONWARD® Medical Accepted to New US FDA TAP Program for Development of its ARC-BCI™ System
EINDHOVEN, the Netherlands, March 11, 2024 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence